MOOLEC SCIENCE SA |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.445 USD | -0.34% |
|
+3.57% | -41.06% |
| 04-22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
| 04-22 | Moolec Science's Modified Soybean Not Subject to Regulation, US Department of Agriculture Says; Shares Rise | MT |
| Sales 2024 * | 3.84M 306M | Sales 2025 * | 6.15M 489M | Capitalization | 54.47M 4.34B |
|---|---|---|---|---|---|
| Net income 2024 * | -9M -716M | Net income 2025 * | -9M -716M | EV / Sales 2024 * | 14.2 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 8.86 x |
| P/E ratio 2024 * |
-5.8
x | P/E ratio 2025 * |
-6.04
x | Employees | 45 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 19.72% |
More Fundamentals
* Assessed data
More news
Latest transcript on Moolec Science SA
| 1 day | +1.72% | ||
| 1 week | +3.57% | ||
| Current month | +5.07% | ||
| 1 month | +5.07% | ||
| 3 months | -20.77% | ||
| 6 months | -47.27% | ||
| Current year | -41.06% |
1 week
1.30
2.15
1 month
1.153.25
Current year
1.153.25
1 year
1.154.40
3 years
1.1542.25
5 years
1.1542.25
10 years
1.1542.25
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/04/24 | 1.45 | +2.11% | 308 796 |
| 25/04/24 | 1.42 | -2.74% | 320,801 |
| 24/04/24 | 1.46 | -15.61% | 909,730 |
| 23/04/24 | 1.73 | -29.96% | 3,161,028 |
| 22/04/24 | 2.47 | +76.43% | 79,683,017 |
End-of-day quote Nasdaq, April 25, 2024
More quotes
Moolec Science SA is a science-based food ingredient company. The Company focuses on developing real animal proteins in plants using Molecular Farming, which is a sustainable technology. It operates in the United States, Europe, and South America. The Company's technology allows it to include animal proteins' gene deoxyribonucleic acid (DNA) codes inside the genome of the main plants used in food. Each protein is selected to add value in terms of targeted functionality, such as taste, texture, and nutritional values.
Sector
Fishing & Farming
Calendar
28/05/2024
- Q3 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.45
USD
Average target price
6
USD
Spread / Average Target
+313.79%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -41.06% | 54.47M | |
| +12.96% | 3.29B | |
| -95.58% | 1.61B | |
| +1.33% | 1.61B | |
| -1.58% | 1.25B | |
| -2.19% | 1.22B | |
| -.--% | 1.22B | |
| -12.02% | 1.21B | |
| -8.52% | 1.2B | |
| 0.00% | 1.19B |
- Stock Market
- Equities
- MLEC Stock
